Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Tables)

v3.5.0.2
Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
The following table presents a summary of the Company’s financial instruments that are measured on a recurring basis:
 
 
 
Fair Value Measurements at September 30, 2016
 
Balance at September 30, 2016
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(in thousands)
Assets
 
 
 
 
 
 
 
Money market funds
$
115

 
$
115

 
$

 
$

Government debt securities
24,033

 

 
24,033

 

Corporate debt securities
30,133

 

 
30,133

 

 
$
54,281

 
$
115

 
$
54,166

 
$

Liabilities
 
 
 
 
 
 
 
Contingent consideration
$
364

 
$

 
$

 
$
364

 
$
364

 
$

 
$

 
$
364

 
 
 
Fair Value Measurements at December 31, 2015
 
Balance at December 31, 2015
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(in thousands)
Assets
 
 
 
 
 
 
 
Money market funds
$
17,144

 
$
17,144

 
$

 
$

Government debt securities
17,273

 

 
17,273

 

Corporate debt securities
45,269

 

 
45,269

 

 
$
79,686

 
$
17,144

 
$
62,542

 
$

Liabilities
 
 
 
 
 
 
 
Contingent consideration
$
395

 
$

 
$

 
$
395

 
$
395

 
$

 
$

 
$
395

Available-for-sale Securities [Table Text Block]
The composition of financial instruments is as follows:
 
September 30, 2016
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
Gains
 
Losses
 
 
(in thousands)
Assets
 
 
 
 
 
 
 
Money market funds
$
115

 
$

 
$

 
$
115

Government debt securities
24,031

 
5

 
(3
)
 
24,033

Corporate debt securities
30,133

 
2

 
(2
)
 
30,133

 
54,279

 
7

 
(5
)
 
54,281

Less amounts included in cash and cash equivalents
(115
)
 

 

 
(115
)
 
$
54,164

 
$
7

 
$
(5
)
 
$
54,166

 
Fair Value at September 30, 2016
 
(in thousands)
Liabilities
 
Contingent Consideration
$
364

Total
$
364

 
December 31, 2015
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
Gains
 
Losses
 
 
(in thousands)
Assets
 
 
 
 
 
 
 
Money market funds
$
17,144

 
$

 
$

 
$
17,144

Government debt securities
17,303

 

 
(30
)
 
17,273

Corporate debt securities
45,353

 

 
(84
)
 
45,269

 
79,800

 

 
(114
)
 
79,686

Less amounts included in cash and cash equivalents
(17,144
)
 

 

 
(17,144
)
 
$
62,656

 
$

 
$
(114
)
 
$
62,542


 
Fair Value at December 31, 2015
 
(in thousands)
Liabilities
 
Contingent Consideration
$
395

Total
$
395

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following summarizes the activity in Level 3 financial instruments:
 
Nine Months Ended September 30,
 
2016
 
2015
 
(in thousands)
Contingent Consideration (1)
 
 
 
Beginning balance
$
395

 
$
265

Physpeed earn-out payment
(240
)
 

Loss (gain) recognized in earnings (2)
209

 
(123
)
Ending balance
$
364

 
$
142

Net (loss) gain for the period included in earnings attributable to contingent consideration held at the end of the period
$
(209
)
 
$
123

____________________________